InvestorsHub Logo
Followers 14
Posts 1732
Boards Moderated 0
Alias Born 04/07/2014

Re: uksausage post# 148482

Tuesday, 08/14/2018 6:06:50 AM

Tuesday, August 14, 2018 6:06:50 AM

Post# of 330165
Agree! I stated in an earlier post that BIEL'S CEO himself said expect the FDA clearance response in 90 days after submission. But yet, I got pushback on this board. It makes no sense unless you read between the lines. Thus, I think I know why some post's content is contrary to what any reasonable observer would expect. But let's put that item aside and engage in a little bit of trivia, and reason. Now Lloyds, which headquartered in the UK, is a subsidiary of Celesio, a German company; The majority owner of Celesio is an American company, McKesson Corporation. In 2017, McKesson recorded revenues of $198.5 billion. Wow!! I think that's greater than Amazon in 2017! Now one would think this mega company can afford to advertise a product which is touted to be the next great thing in the way of a drugless analgesic? As I recall, someone on this board posted that AW said, initially, he would rely on his affiliates to advertise for him. So, if that's true, then why aren't these second parties picking up the baton and advertising? Most of these affiliate companies are not based within the U.S., so the FDA is not in play. So why are they not advertising in a big way? I'm just saying something just doesn't figure here!!

That's My Take!!

GLTA!!!

P.S. A little secret... just maybe someone told them not to seriously advertise at this time, for whatever reason. Huh! y'all!